Jumawan, Zyra Belle E.
HRN: 28-37-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
MUPIROCIN 2%, 15G (TUBE)
04/06/2026
04/12/2026
TOPICAL
-
TID
T/C Omphalitis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: